ALHC Form 144 for sale of 177,068 shares

A Form 144 notice for ALHC covers a proposed sale of up to 177,068 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $3,753,841.60 and 206,733,823 shares outstanding.

Rhea-AI Filing Summary

A Form 144 notice for ALHC covers a proposed sale of up to 177,068 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $3,753,841.60 and 206,733,823 shares outstanding. The shares include stock acquired via Exercise of Stock Options and RSU/PSU awards. It also lists prior 10b5-1 sales of 30,000 shares on May 15, 2026, for $482,567.00 and 30,000 shares on June 15, 2026, for $586,424.50.

Key Figures

Shares proposed for sale: 177,068 shares Aggregate market value: $3,753,841.60 Shares outstanding: 206,733,823 shares +4 more

7 metrics

Shares proposed for sale 177,068 shares Common stock covered by Form 144 notice

Aggregate market value $3,753,841.60 Value of 177,068 shares proposed for sale

Shares outstanding 206,733,823 shares ALHC common shares outstanding referenced in notice

Option-related shares 152,068 shares Common shares from Exercise of Stock Options dated 07/15/2026

RSU/PSU-related shares 25,000 shares Common shares from RSU/PSU awards dated 09/25/2020

Sale on 06/15/2026 30,000 shares for $586,424.50 10b5-1 sale of common stock for Dawn Maroney

Sale on 05/15/2026 30,000 shares for $482,567.00 10b5-1 sale of common stock for Dawn Maroney

Key Terms

Form 144, 10b5-1, Exercise of Stock Options, RSU/PSU, +1 more

5 terms

Form 144 regulatory

"Form 144 notice for ALHC covers a proposed sale of shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for Dawn Maroney 1100 W. Town and Country Road"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 07/15/2026 | Exercise of Stock Options | Issuer"

RSU/PSU financial

"Common | 09/25/2020 | RSU/PSU | Issuer"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALHC shares are proposed to be sold under this Form 144?

The Form 144 covers a proposed sale of 177,068 ALHC common shares. These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, as indicated in the notice.

What is the aggregate market value of the ALHC shares in this Form 144?

The aggregate market value of the 177,068 ALHC common shares is $3,753,841.60. This value reflects the proposed sale reported in the Form 144 notice for trading on NASDAQ.

What types of ALHC securities underlie the shares in this Form 144?

The shares relate to ALHC common stock from an Exercise of Stock Options dated July 15, 2026, and RSU/PSU awards dated September 25, 2020. Both sources contribute to the total shares covered.

Which broker is listed for the proposed ALHC share sale?

The proposed sale uses Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. This broker is named in the Form 144 notice for the NASDAQ transaction.

What prior ALHC share sales are disclosed for the past 3 months?

The notice lists 10b5-1 sales of 30,000 ALHC common shares on May 15, 2026 for $482,567.00 and 30,000 shares on June 15, 2026 for $586,424.50, associated with Dawn Maroney.

How many ALHC shares were acquired via stock options versus RSU/PSU awards?

The Form 144 indicates 152,068 ALHC common shares tied to an Exercise of Stock Options dated July 15, 2026, and 25,000 shares associated with RSU/PSU awards dated September 25, 2020.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/15/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001850397
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALIGNMENT HEALTHCARE INC
SEC File Number	001-40295
Address of Issuer	1100 W. Town and Country Road Orange CALIFORNIA 92868
Phone	8443102247
Name of Person for Whose Account the Securities are To Be Sold	DAWN MARONEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	177068	3753841.60	206733823	07/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/15/2026	Exercise of Stock Options	Issuer			152068	07/15/2026	Cash
Common	09/25/2020	RSU/PSU	Issuer			25000	09/25/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DAWN MARONEY 1100 W. Town and Country Road Orange CA 92868	Common	06/15/2026	30000	586424.50
10b5-1 Sales for DAWN MARONEY 1100 W. Town and Country Road Orange CA 92868	Common	05/15/2026	30000	482567.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units and performance stock units during the period of 09/25/2020 through 03/13/2026.
Date of Notice	07/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Dawn Maroney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)